SG Americas Securities
BLTE

SG Americas Securities’s Belite Bio BLTE Stock Holding History

SG Americas Securities’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$342K Sell
2,144
-611
-22% -$103K ﹤0.01% 2387
2025
Q4 		$441K Buy
+2,755
New +$326K ﹤0.01% 2570

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SG Americas Securities's BLTE Position: Q1 2026 in Review

SG Americas Securities reduced its Belite Bio (BLTE) stake by 22% in Q1 2026, selling an estimated $103K and leaving 2,144 shares worth $342K. The position accounts for ﹤0.01% of the portfolio, ranked #2387.

SG Americas Securities first reported a position in BLTE in Q4 2025 and has held it in 2 quarters since. The position peaked at $441K in Q4 2025. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

  • SG Americas Securities held 2,144 shares of Belite Bio worth $342K as of Q1 2026.
  • SG Americas Securities sold 611 Belite Bio shares in Q1 2026, an estimated $103K.
  • Belite Bio made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2387 holding.
  • SG Americas Securities first reported a position in Belite Bio in Q4 2025 and has held it in 2 quarters since.
  • SG Americas Securities's Belite Bio position peaked at $441K in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.